ARTICLE | Distillery Therapeutics
Renal
December 13, 2017 1:10 AM UTC
Cell culture and rat studies identified a benzimidazole-based TRPC5 inhibitor that could help treat focal segmental glomerulosclerosis (FSGS). Chemical synthesis and testing in HEK cell-based ion chan...